I asked everyone what Dark Horse should investigate next. Looking back, I asked the wrong question. I don't need a list of subjects for me to research. We already have more research directions than we have time. What I'm interested in is what YOU are researching So, here's the question I should have asked: WHAT HAVE YOU BEEN DIGGING INTO? Bring to the community what you've actually been researching. Not simply a topic you'd like Dark Horse to research. Something you've been digging into yourself. Maybe it's a peptide, bioregulator, delivery method, pathway, study, protocol concept—or something completely outside the areas we've already discussed. What caught your attention? What have you learned so far? And what questions are you still trying to answer? You don't need to have it figured out. You don't need to write a research paper. And we certainly don't need to be experts. Just bring something to the table. We've covered a tremendous number of subjects. Some were intentionally high-level introductions—not deep dives—while others focused on going much deeper. Maybe one of them sent you down your own rabbit hole. If it did, tell us where it took you. I'd really like to see more people involved in the discussion and see us start learning from each other's research, rather than every conversation beginning with Dark Horse. So—what have YOU been digging into?

We've covered a LOT of ground in Dark Horse. Peptides. Mitochondrial health. Bioregulators. Immune function. Testing. Vendor quality. HGH. Research protocols. Tracking. And plenty of things in between. I've intentionally stayed away from making GLP-1s a major focus because there are already countless communities built almost entirely around them. But here's the thing. I don't want every discussion topic in this community coming from me. There are enough people here with different experiences, different interests and different research objectives that somebody has to be thinking: "Why haven't we talked about ______ yet?" So I'm putting this one on YOU. What do you want Dark Horse to investigate next? It could be a peptide we haven't discussed. A compound you've been seeing mentioned everywhere but don't really understand. Something related to aging, recovery, metabolism, sleep, cognition, inflammation, mitochondrial function, performance or longevity. A study you came across that you want someone to tear apart. Or something completely outside the areas we normally discuss that you think deserves a closer look. Drop ONE topic below. Don't worry about whether you know enough about it to start a discussion. That's the whole point. We'll do the digging together.

TA-1 + LL-37 Back to school is here — and right behind it comes the usual increase in colds, flu, respiratory bugs and everything else that starts making the rounds this time of year. So, if there was ever a good time to start looking at immune-support research, this is it. One combination that deserves some attention: 🛡️ THYMOSIN ALPHA-1 + LL-37 Think of it this way: TA-1 helps organize the defense. LL-37 works closer to the front line. Two very different peptides. Two very different jobs. 🛡️ THYMOSIN ALPHA-1 — THE DIRECTOR TA-1 is all about immune coordination. TA-1 helps the immune system identify threats, coordinate the response, and activate the cells involved in fighting them. It has been researched for its effects on: • T-cell activity • Immune-cell communication • Immune signaling • Adaptive immune response In simple terms, TA-1 helps the immune system recognize what it is dealing with and mount a more organized response. ⚔️ LL-37 — THE FRONTLINE DEFENDER LL-37 plays a completely different role. It is a naturally occurring human antimicrobial peptide and part of the body’s innate immune defense system. Research has looked at its activity involving: • Bacteria • Fungi • Certain viruses • Inflammation and immune signaling • Tissue repair and wound healing This is much closer to the body’s first line of defense. 🔥 WHY PUT THE TWO TOGETHER? Because you are not asking two compounds to do the same job. TA-1 → helps coordinate the immune response LL-37 → works on the innate-defense side of the equation That is what makes the combination interesting. Instead of looking at immune support from one direction, you are looking at two different arms of the immune system at the same time. And heading into cold and flu season? That makes TA-1 + LL-37 a research combination worth knowing about. Who here has researched TA-1, LL-37, or the combination? And if you have used either one in your own research, what did you notice?

SS-31 Mitochondrial Restoration Once the mitochondrial assessment points toward impaired mitochondrial function, the objective changes from optimization to restoration. This is where SS-31 (Elamipretide) comes into the picture. 🔧 SS-31 — THE ENGINE REPAIR KIT SS-31 is a mitochondrial-targeted peptide with an affinity for the inner mitochondrial membrane—the highly folded internal membrane where the electron transport chain operates and most cellular ATP is produced. Central to that membrane is cardiolipin. Cardiolipin is a unique and essential phospholipid found almost exclusively within the inner mitochondrial membrane, where it accounts for roughly 20% of its lipid composition. It is often referred to as the “signature lipid” of mitochondria because of the important role it plays in mitochondrial structure and cellular energy production. Cardiolipin helps organize and stabilize the inner mitochondrial membrane and supports the protein complexes that make up the electron transport chain—the machinery responsible for producing most of our ATP. When cardiolipin becomes damaged or oxidized, that organization can begin to break down. Electron transport becomes less efficient, oxidative stress can increase, and the mitochondria may become less efficient at converting nutrients and oxygen into usable cellular energy. This is the environment SS-31 targets. SS-31 interacts with cardiolipin at the inner mitochondrial membrane. Research suggests this interaction can help stabilize the membrane environment, support the organization and function of the respiratory machinery, improve mitochondrial bioenergetics and reduce excessive mitochondrial oxidative stress. The potential result is a mitochondrial environment better equipped to do what it was designed to do: Produce ATP efficiently. That's why SS-31 fits the Repair the Engine concept. We're not trying to push the engine harder. We're working on the machinery responsible for producing the power in the first place. ⚙️ THE 8-WEEK SS-31 RESTORATION PROTOCOL

Hope everyone gets a chance today to slow down, enjoy the day, and spend some time with family and friends. Whether you’re relaxing, grilling, getting outside, or doing absolutely nothing for a change — enjoy it. Happy Labor Day from Dark Horse. 🐎